Researchers use living host cells as production centers to make drug items, such as biologics and therapeutic recombinant proteins. Cells present a source of irregularity and an unique set of technical difficulties to biopharmaceutical production. Researchers require an early awareness of the obstacles that might hinder an efficient advancement process to make educated job decisions. Download this white paper from Sartorius to find solutions to mistaken decision-making when establishing robust, dependable, and high-yielding cell lines.Sponsored by
